Sign in
4

Changes in Ownership

Imunon, Inc. Filed Acc 0001437749-22-005439

Options or other derivatives

  • Chairman, President and CEO acquired 80,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Tardugno Michael H · Chairman, President and CEO

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-03-04 Grant or award : show line 1 in the form Option to Purchase Celsion Common Stock +80,000 213,068 D
Loading xslF345X03/rdgdoc.xml…